Hello everyone,
We need your help. The Scottish Medicines Consortium (SMC) are assessing whether or not to recommend pertuzumab (Perjeta) to be available on the NHS in Scotland. Pertuzumab for treating HER2 positive secondary breast cancer is available on the NHS to women who live in England, Wales and Northern Ireland, but it’s not currently available in Scotland.
We are gathering evidence to tell the SMC what access to pertuzumab would mean and want to hear from: women who have been or are being treated with pertuzumab for secondary breast cancer in England, Wales and Northern Ireland, or women in Scotland who have HER2 positive secondary breast cancer.
Please help us by completing our short survey: surveymonkey.co.uk/r/TJ2G7JZ
We are looking for responses by Monday 29 October.
If you have any questions about our work in this area, please email campaigns@breastcancercare.org.uk.
Thanks for your help as always,
Olivia